Increased Level of Thrombotic Biomarkers in Patients with Atrial Fibrillation Despite Traditional and New Anticoagulant Therapy
Jeffrey Liles(Loyola University Chicago), Jawed Fareed(Loyola University Medical Center), Christopher Wanderling(University of Rochester), Debra Hoppensteadt(Loyola University Medical Center), Mushabbar Syed(Loyola University Medical Center), Jordan Liles(Loyola University Chicago)
Cited by 19
Related Papers
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Nailfold Capillary Abnormalities in Primary Open-Angle Glaucoma: A Multisite Study
|Investigative Ophthalmology & Visual Science|2015|38
Recent Advances in Surgical Simulation For Resident Education
|Current Urology Reports|2023|30
Dysregulation of Tissue Factor, Thrombin-Activatable Fibrinolysis Inhibitor, and Fibrinogen in Patients Undergoing Total Joint Arthroplasty
|Clinical and Applied Thrombosis/Hemostasis|2017|19
Perioperative Factors and Their Effect on the Fibrinolytic System in Arthroplasty Patients
|Clinical and Applied Thrombosis/Hemostasis|2015|13